Impact of abciximab on prognosis in diabetic patients undergoing primary percutaneous coronary intervention.
Perkan A, Vitrella G, Barbati G, De Monte A, D'Agata B, Merlo M, Giannini F, Della Grazia E, Rakar S, Salvi A, Igidbashian D, Morgera T, Zalukar W, Sinagra G.
Perkan A, et al. Among authors: vitrella g.
J Cardiovasc Med (Hagerstown). 2013 Feb;14(2):127-35. doi: 10.2459/JCM.0b013e32834eec7a.
J Cardiovasc Med (Hagerstown). 2013.
PMID: 22343257